UPDATE
: Monday, December 9, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
HOME
Pharma
Astellas wins nod for phase-3 trial on gastric cancer treatment
Lee Hye-seon
승인 2018.09.11 10:38
댓글 0
Comments
0
Please leave the first comment.
Celltrion unveils long-term P3 trial results for Truxima in US
AMC unravels clues in treating relapsing, metastatic bladder cancer
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
AbbVie’s Venclexta nears insurance benefit
Celltrion unveils long-term P3 trial results for Truxima in US
AMC unravels clues in treating relapsing, metastatic bladder cancer
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
AbbVie’s Venclexta nears insurance benefit
여백
Most viewed
1
Technology developed to detect inflammatory disorders early
2
'Insulin is safe, natural replacement therapy for diabetic patients'
3
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
4
Samyang Biopharm’s US subsidiary to work on new immunotherapy
5
Swedish researchers divide Type 2 diabetes into 5 subgroups
6
Ildong signs co-promotion contract with GSK Consumer Healthcare
7
Korean patient with rare breast cancer to sue Allergan in US
8
Korea exports health insurance system to Bahrain
9
Quick test for meningitis unavailable due to low reimbursement
10
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top